2021
DOI: 10.2147/jir.s332705
|View full text |Cite
|
Sign up to set email alerts
|

SARS-CoV-2: Emerging Role in the Pathogenesis of Various Thyroid Diseases

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
34
0
6

Year Published

2022
2022
2024
2024

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 43 publications
(40 citation statements)
references
References 157 publications
(262 reference statements)
0
34
0
6
Order By: Relevance
“…All cases were successfully treated and completely recovered [ 79 ]. Thyroid cells express the SARS-CoV-2 receptor named angiotensin-converting enzyme 2 (ACE2) as well as transmembrane protease, serine 2 (TMPRSS2) facilitating the virus infectivity [ 80 ]. Thus, SARS-CoV-2 can directly attack the thyroid tissue, leading to gland dysfunction during and after COVID-19.…”
Section: Mechanisms Of Covid-19 Vaccination-induced Thyroid Dysfunctionsmentioning
confidence: 99%
“…All cases were successfully treated and completely recovered [ 79 ]. Thyroid cells express the SARS-CoV-2 receptor named angiotensin-converting enzyme 2 (ACE2) as well as transmembrane protease, serine 2 (TMPRSS2) facilitating the virus infectivity [ 80 ]. Thus, SARS-CoV-2 can directly attack the thyroid tissue, leading to gland dysfunction during and after COVID-19.…”
Section: Mechanisms Of Covid-19 Vaccination-induced Thyroid Dysfunctionsmentioning
confidence: 99%
“…This is also true for thyroid follicular cells that express the ACE-2 receptor that SARS-CoV-2 uses to enter the cells [ 16 ]. There are reports in the literature of cases of GD, Hashimoto's thyroiditis, and subacute thyroiditis developing in the post-COVID-19 period [ 3 ]. Likewise, some autoimmune/inflammatory thyroiditis cases thought to be associated with immunization against COVID-19 are still being reported, with the first GD cases reported in May 2021 [ 13 ].…”
Section: Discussionmentioning
confidence: 99%
“…From this point of view, the emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection-associated autoimmune thyroid diseases (AITD) can be expected. Indeed, some cases of GD and other AITD have been reported following SARS-CoV-2 infection and its immunization [ [3] , [4] , [5] , [6] , [7] , [8] , [9] , [10] , [11] , [12] , [13] ]. When considering the pre-COVID-19 period, in a case report published after the H1N1 pandemic, two newly-diagnosed autoimmune diseases (GD and narcolepsy type 1) had been detected following H1N1 vaccination in a 40-year-old female patient [ 14 ].…”
Section: Introductionmentioning
confidence: 99%
“…Against the background of reports on the possibility of provoking the development of atypical subacute thyroiditis (de Quervain thyroiditis) and Graves' disease [10,15], there is a good opinion that pathological changes in the thyroid gland may be signs of direct action of the virus. The course of such changes and their consequences can be largely determined by the state of the thyroid gland itself, as it plays a leading role in all types of metabolism, growth processes and differentiation of tissues [16].…”
mentioning
confidence: 99%